538 views
Albert Hagège (Paris), Olivier Huttin (Nancy), Catherine Sportouch-Dukhan (Montpellier) and Antonin Trimaille (Strasbourg) take stock of the clinical elements on which to base the treatment of a patient with obstructive HCM, who makes the decision to treat, the therapeutic approach in first and second intention… They also analyze the place of mavacamten in the management and discuss the future of myosin inhibitors in the practice of cardiologists, in this last part of the replay of the special program “How to evaluate, manage and monitor obstructive hypertrophic cardiomyopathy in 2024”. #cmh #cardiology #cardiomyopathies